Based on the key indicators related to Serina Therapeutics' liquidity, profitability, solvency, and operating efficiency, Serina Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January. At this time, Serina Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 12/18/2024, Liabilities And Stockholders Equity is likely to grow to about 12.6 M, while Other Current Liabilities is likely to drop slightly above 791.5 K. Key indicators impacting Serina Therapeutics' financial strength include:
The essential information of the day-to-day investment outlook for Serina Therapeutics includes many different criteria found on its balance sheet. An individual investor should monitor Serina Therapeutics' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Serina Therapeutics.
Comparative valuation techniques use various fundamental indicators to help in determining Serina Therapeutics's current stock value. Our valuation model uses many indicators to compare Serina Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Serina Therapeutics competition to find correlations between indicators driving Serina Therapeutics's intrinsic value. More Info.
Serina Therapeutics is rated third in return on asset category among its peers. It is currently regarded as top stock in profit margin category among its peers . At this time, Serina Therapeutics' Net Loss is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Serina Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Serina Therapeutics Systematic Risk
Serina Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Serina Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Serina Therapeutics correlated with the market. If Beta is less than 0 Serina Therapeutics generally moves in the opposite direction as compared to the market. If Serina Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Serina Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Serina Therapeutics is generally in the same direction as the market. If Beta > 1 Serina Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Serina Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Serina has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Serina Therapeutics' financials are consistent with your investment objective using the following steps:
Review Serina Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
Study the cash flow inflows and outflows to understand Serina Therapeutics' liquidity and solvency.
Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
Compare Serina Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Serina Therapeutics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in Serina Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Serina Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Serina Therapeutics growth as a starting point in their analysis.
Serina Therapeutics December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Serina Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Serina Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Serina Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Serina Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Serina Therapeutics's daily price indicators and compare them against related drivers.
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.